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The mucosal barriers are very sensitive to pathogenic infection, thereby assuming the
capacity of the mucosal immune system to induce protective immunity to harmful antigens
and tolerance against harmless substances. This review provides current information about
mechanisms of induction of mucosal tolerance and about impact of gut microbiota to
mucosal tolerance.
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INTRODUCTION
The human intestine harbors a whole microbial ecosystem con-
taining over 100 trillion microorganisms that collectively have a
total genome (the microbiome) consisting of 100-fold more genes
than the human genome (Tsai and Coyle, 2009). The gut micro-
biota lives in tight symbiosis and homeostasis with the host and
plays an essential role in harvesting energy, minerals, and bioac-
tive compounds from the food. The intestinal microbiota exists
in reciprocal balance with the gut-associated lymphoid tissue
(GALT), the largest immune system in the body. Gut microor-
ganisms are the major source of natural antigens that continu-
ously stimulate the GALT and induce mucosal immune tolerance
(e.g., local or systemic immune unresponsiveness) to innocuous
antigens such as food proteins and molecular components of
commensal bacteria (Pabst and Mowat, 2012). In addition, the
GALT is necessary for preventing acute proinflammatory immune
responses against the microbiota resulting in inflammatory bowel
diseases or against food protein causing food allergy and celiac
disease. The mucosal barriers are very sensitive to pathogenic
infection thereby assuming the capacity of the mucosal immune
system to induce protective immunity to harmful antigens and
tolerance against harmless materials (Weiner et al., 2011).
Oral tolerance is a phenomenon of suppressing immune
responses in the gut and systemic immune system by orally
administered antigens. Tolerance to intestinal bacteria and tol-
erance to food proteins differs by its effects on the immune
system. Tolerance to food protein induced through the small
intestine influences both local and systemic immune responses,
while tolerance to gut bacteria in the colon does not attenuate
systemic responses (Pabst and Mowat, 2012). Oral tolerance was
extensively studied in rodents using many different antigens such
as purified proteins, cellular antigens, and small haptens. The
phenomenon of oral tolerance was also described in humans
(Kraus et al., 2004; Kapp et al., 2010). The effects of oral tolerance
on the immune system were usually evaluated as a suppression
of cytokine production and T-cell proliferation and decrease in
serum titers of circulating antibodies. The ability of oral tol-
erance to inhibit autoimmune and inflammatory diseases was
demonstrated in rodent experimental models of type 1 diabetes,
encephalomyelitis, arthritis, myasthenia, thyroiditis, and other
pathology (Faria and Weiner, 2006). Thus, oral tolerance is able to
diminish a broad spectrum of immune responses and hence could
play a key role in maintaining peripheral immune homeostasis.
MECHANISMS OF INDUCTION OF MUCOSAL TOLERANCE
INTESTINAL INTAKE OF TOLEROGENIC ANTIGEN
The intestinal immune system is composed by several essential
components such as GALT [Peyer’s patches (PPs) and isolated
lymphoid follicles (ILFs)] and gut-draining mesenteric lymph
nodes (mLNs), which primarily contribute to the induction of
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mucosal tolerance through recognition of colon-derived bacterial
and viral antigens (Brandtzaeg et al., 2008). In the epithelium
of PPs and ILFs, specialized epithelial cells called as microfold
cells (M cells) are involved in the permanent transfer of colon
material from the gut lumen into the GALT (Miller et al., 2007).
The intestinal antigen is then passed from M cells on to dendritic
cells (DCs) that reside either below the epithelium or in a “pocket”
created at the basolateral surface of the M cell. Antigen uptake
by DCs in the lamina propria (LP) underlying regular villus
epithelium was shown to be critical for inducing tolerance to
soluble antigens in the small intestine (Chirdo et al., 2005).
There are several possible mechanisms of delivery of intestinal
antigens from the lumen to DCs. Low-molecular antigens such
as haptens and peptides could diffuse through the intestinal
epithelium via pores in inter-epithelial tight junctions (Hossain
and Hirata, 2008). High-molecular complexes can be taken across
enterocytes by transcytosis or through exosome-mediated path-
way associated with major histocompatibility complex (MHC)
class II-dependent recognition and antigen processing (Menard
et al., 2010). DCs were shown to efficiently uptake exosomes. The
exosomes containing MHC class II associated with gut antigenic
peptides were able to induce tolerance in recipient mice after
isolation from serum of antigen-fed animals (Karlsson et al.,
2001).
In fact, the antigen nature drives its path of uptake. Particulate
material and microbiota are mainly delivered into the GALT by
transcytosis throught M cells while soluble antigens induce oral
tolerance after DC-mediated intake mostly in the LP and then in
the GALT.
DISSEMINATION OF GUT ANTIGEN WITHIN THE BODY
Orally administered antigens are likely to disseminate across the
body through the circulation. For example, food protein can be
found in the blood of humans soon after meal intake (Husby
et al., 1985). The antigen entry to the bloodstream occurs not
simply but is accompanied with detectable changes in the mucosal
immune system including activation of C-type lectin (marker
CD69) expression and T cells in mLNs and peripheral LNs (Smith
et al., 2002). Furthermore, since serum-derived exosomes from
antigen-fed animals could induce tolerance in naïve recipient
animals, this phenomenon indicates the presence of tolerogenic
material (Karlsson et al., 2001, 2010). Indeed, it is important to
know where in the body the gut antigen induces oral tolerance.
The administration of an antigen into the portal vein induces
tolerance that is specific to the antigen (Thomson and Knolle,
2010) whereas disruption of the intrahepatic blood flow by the
portocaval shunt prevents oral tolerance induction (Yang et al.,
1994). These findings support the liver as a likely tolerogenic site
for gut antigen. Furthermore, the liver is anatomically located as
the endpoint of the portal vein delivering blood directly from the
intestine.
The liver is enriched with specialized antigen-presenting cells
(APCs) that could be primarily involved in the tolerance induc-
tion. Kupffer cells and conventional hepatic DCs belong to profes-
sional APCs challenging immune responses against gut antigens
in favor to inducing and maintaining tolerance (Thomson and
Knolle, 2010). In addition, hepatic sinusoidal endothelial cells are
able to collect circulating antigens and act as APCs in inducing
tolerance (Limmer et al., 2005; Holz et al., 2010). In the liver, plas-
macytoid DCs especially contribute to the induction of systemic
tolerance to orally administered antigens by down-regulating and
initiating anergy in antigen-specific CD4+ and CD8+ T cells
(Goubier et al., 2008; Dubois et al., 2009).
In the spleen and peripheral LNs that are located beyond the
liver, resident DCs could trigger local and systemic tolerance to the
gut-derived antigen even the absence of costimulation through
initiating anergy in effector T cells or inducing regulatory T
cells (Tregs; Yamazaki et al., 2008) but with less efficiency than
GALT-associated DCs do (Hashiguchi et al., 2011). However, it
is likely that intestinal DCs play a key role in inducing systemic
tolerance.
GALT-ASSOCIATED DCs PLAY A CRUCIAL ROLE IN INDUCING ORAL
TOLERANCE
Gut antigen-induced CD103+ DCs migrating from the LP to
mLNs are responsible for major delivery and recognition of colon-
derived antigens in the GALT (Pabst et al., 2007). The travel of
DCs from LPs to mLNs is dependent on C-C chemokine receptor
(CCR) 7, a chemokine receptor (Forster et al., 2008). The lack of
all LNs and PP in lymphotoxin α-deficient mice leads to the loss
of oral tolerance that could be restored by specifically induced
mLN formation (Spahn et al., 2002). Similarly, surgical deletion
of mLNs in mice abolishes the induction of oral tolerance (Worbs
et al., 2006). These findings suggest that the intestine immune
system and especially mLNs have a primary role in the induction
of oral tolerance.
Gut-associated lymphoid tissue-associated DCs that express
on their surface integrin chain-αE (CD103) never reach the
circulation beyond mLNs (Milling et al., 2010). In LPs, intestinal
CD103+ DCs recognize gut antigens and possess tolerogenic and
immunoregulatory properties stimulating expression of homing
molecules CCR7 and integrin-αIVβ7 on T cells resided in the
mLNs and inducing Forkhead box protein 3 (FoxP3)-positive
Tregs (Johansson-Lindbom et al., 2005; Sun et al., 2007; Jaensson
et al., 2008; Worthington et al., 2011). Gut-derived vitamin A and
other retinoids were shown to modulate homing-inducing and
tolerogenic properties of CD103+cells by inducing synthesis of
homing molecules CCR9 and CCR4 (Iwata et al., 2004; Jaensson-
Gyllenbäck et al., 2011). Retinoic acid was reported to down-
regulate experimentally induced intestinal inflammation (ileitis)
by restoring the balance between proinflammatory Th17 cells
and inducible CD4+FoxP3+ Tregs (iTregs) in the mouse (Collins
et al., 2011). Furthermore, retinoic acid produced by CD103+DCs
cooperates with transforming growth factor-β (TGF-β) in gener-
ation of iTregs from naive CD4+T cells (Sun et al., 2007). The
integrin-αIVβ7 was found to be significantly up-regulated on the
surface of CD103+DCs and activates latent TGF-β by releasing
it from the complex with latent TGF-β-binding protein (LTBP)
thereby mediating TGF-β-dependent induction of Tregs (Païdassi
et al., 2011; Worthington et al., 2011). Intestinal inflammation
impairs function of GALT-associated CD103+ cells and abolishes
their tolerogenic activities (Laffont et al., 2010).
CD103+ DCs were observed to cooperate with other cell types
presented in the intestinal mucosa to induce gut tropism in T
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cells and oral tolerance. In mLNs, non-hematopoietic stromal
cells are essential for full display of ability of GALT-associated
DCs to induce gut-homing T cells (Hammerschmidt et al., 2008).
Notably, stromal cells taken from peripheral LNs failed to initiate
gut tropism in T cells. Furthermore, mLN-derived stromal cells
produce high levels of retinoic acid-metabolizing enzymes that
are essential for retinoic acid-mediated induction of synthesis
of homing molecules (Molenaar et al., 2009). Similarly, stromal
cells from mLNs but not from skin-draining LNs support the
generation of Foxp3+ Tregs (Cording et al., 2014). Thus, gut-
specific environment and synergistic interactions of mLN-derived
stromal and DCs play a crucial role in induction of intestinal T cell
homing and gut-associated Tregs.
Recently, a new population of intestinal CD103− DCs was
identified (Cerovic et al., 2013). Like CD103+ DCs, these cells
are responsive to Flt3 (FMS-like tyrosine kinase 3), a regu-
latory factor crucial for the hematopoietic commitment and
functional and phenotypic maintenance of DCs, and prime a gut-
homing phenotype to naive T cells in the mLNs. CD103−CD11b+
CX3CR1int lymph DC subset induce the differentiation of
proinflammatory interferon (IFN)-γ and interleukin (IL-17)-17-
producing effector T cells (Cerovic et al., 2013). Administra-
tion of Flt3 ligand resulted in inducing CD103 expression in
CD103− DCs and converting these cells from proinflammatory
to tolerogenic CD103+ DCs that contributed to generation of
CD4+FoxP3+ Tregs and attenuation of experimental Crohn’s-like
ileitis (Collins et al., 2012). Therefore, local microenvironment
and proinflammatory/anti-inflammatory stimuli could greatly
influence the phenotype and function of GALT-associated DCs.
MECHANISMS OF ORAL TOLERANCE INDUCTION
Oral tolerance utilizes mechanisms similar with those of the
peripheral immune tolerance including active impact of Tregs,
clonal deletion, and clonal anergy of T cells. Antigen doses were
shown to influence the choice of tolerogenic mechanisms and
numbers of iTregs (Weiner et al., 2011). In exposure to a single
high dose of antigen, clonal deletion or anergy are preferential
tolerogenic mechanisms whereas numerous low antigen doses
induce T cell anergy (Chen et al., 1996). In oral tolerance, the
highest counts of Foxp3+ Tregs were induced after exposure to
the high doses of an antigen (Siewert et al., 2008).
Inducible Tregs generated with contribution of intestinal
CD103+ DCs and mLN-specific stromal cells appears to play a
key role in induction and maintenance of oral tolerance. Several
subsets of Tregs such as CD4+FoxP3+ iTregs, IL-10-producing
regulatory type 1 cells (Tr1), and TGF-β-producing Th3 Tregs
were shown to be involved in oral tolerance (Pabst and Mowat,
2012). Adoptive transfer of CD4+CD25+FoxP3+ Tregs from
tolerogenic animals could induce oral tolerance in naïve mice
whereas depletion of FoxP3+Tregs abolishes tolerance (Dubois
et al., 2003). FoxP3+ and FoxP3− IL-10-producing Tregs were
found in the gut mucosa (Maynard et al., 2007). Interestingly,
all-trans retinoic acid was shown to have reciprocal effects on
induction of Foxp3 and IL-10 in developing CD4+ Tregs. By
enhancing TGF-β-dependent Foxp3 induction, all-trans retinoic
acid inhibits TGF-β-dependent induction of IL-10-producing
Tregs. Toll-like receptor (TLR)-9-mediated suppression of all-
trans retinoic acid production by GALT-associated DCs alter-
nately induces preferential expression of IL-10 in Tregs (Maynard
et al., 2009).
Among subsets of Tregs, the role of FoxP3+ Tregs [e.g., natural
CD4+CD25+FoxP3+ Tregs (nTregs) and iTregs] in oral tolerance
is the best studied (Curotto de Lafaille et al., 2009). nTregs are
selected in the thymus and are responsible for driving central
tolerance whereas iTregs are induced in the periphery and are
accordingly involved in the regulation of peripheral tolerance.
In changing microenvironmental conditions, nTregs maintain
a stable phenotype although their function could be impaired
(Rubtsov et al., 2010). In contrast, iTregs have a plasticity to
differentiate to other helper T cell types under inflammatory
stimuli (Koenecke et al., 2009). However, in steady-state non-
inflammatory conditions, FoxP3+ Tregs can induce and maintain
oral tolerance for a long time. Interestingly, in a mouse model,
nTregs were unable to induce tolerance to oral ovalbumin while
iTregs did suggesting for the obligatory need in peripheral con-
version of naïve CD4+ T cells to iTregs (Curotto de Lafaille et al.,
2008).
Indeed, mLNs provide an essential gut-specific microenviron-
ment for selective differentiation of iTregs (Hadis et al., 2011).
MAINTENANCE OF ORAL TOLERANCE
Assuming that the mucosal immune system every day should
respond to new intestinal antigens and oral tolerance to a spe-
cific antigen could be maintained for several months, iTregs are
likely to be continuously generated in the GALT (Strobel and
Ferguson, 1987). Induction and maintenance of oral tolerance
is a multi-stage process involving lymphoid and mucosal tissues
(Hadis et al., 2011). After induction in mLNs, iTregs should
keep gut-specific homing for long-term supporting oral toler-
ance. Expression of homing molecules such as integrin-β7 and
its ligand MadCAM-1 (mucosal vascular addressin cell adhesion
molecule 1) is essential for supporting GALT-associated homing
of newly generated iTregs (Wagner et al., 1996; Gorfu et al., 2009).
Depletion of these two molecules results in greatly diminished and
impaired oral tolerance that could be restored by adoptive transfer
of integrin-β7-positive T cells (Hadis et al., 2011).
CCR9 was shown to be crucial for the maintenance of GALT-
associated homing of T cells since CCR9-null mice have marked
defects in oral tolerance (Cassani et al., 2011). CCR9 and integrin-
αIVβ7 are both required for small intestine-specific homing of
immune cells (Svensson et al., 2002; Stenstad et al., 2007).
Retinoic acid is required for induction of CCR9 expression in T
cells. Activation of the retinoic acid receptor (RAR) and retinoid
X receptor (RXR) results in expression of high levels of CCR9,
integrin-αIVβ7, and FoxP3 essential for differentiation of naïve T
cells to iTregs and their homing in the small-intestine-associated
GALT (Takeuchi et al., 2010).
In the small intestine LP, iTregs induced in mLNs are sub-
jected to secondary expansion that is mediated by the chemokine
receptor CX3CR. This receptor is also crucial for induction of
oral tolerance because CX3CR-null mice lack oral tolerance. In
the LP of CX3CR-null mice, myeloid cells secrete less IL-10,
and its production could be rescued by adoptive transfer of
wild-type macrophages that express IL-10 (Hadis et al., 2011).
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Due to decreased production of IL-10, generation of iTregs is
suppressed in CX3CR-null mice, an event, which in turn abro-
gates the induction of oral tolerance (Murai et al., 2009). IL-10-
producing intestinal mucosa-resident macrophages could there-
fore contribute to maintenance of iTregs and iTregs-dependent
oral tolerance (Gonnella et al., 1998).
Indeed, oral tolerance associated with the small intestine is
induced by the cooperative action of mLN-derived CD103+
DCs and stromal cells that produce retinoic acid required for
imprinting of gut-homing molecules on specific T cells. Certain
T cells differentiate to iTregs that leave the mLN and home
to the small intestine where they undergo secondary expansion
activated by IL-10-secreting CX3CRhigh myeloid cells and resi-
dent macrophages. Some secondarily expanded Tregs can pos-
sibly leave the GALT and enter the circulation via lymphatic
vessels or directly to the bloodstream thereby contributing to
expanding tolerance to orally administered antigen from local
(e.g., gut-associated) to systemic tolerance. The mechanism of
establishment of systemic oral tolerance could be similar with the
trafficking of CD4+Foxp3+ Tregs from skin draining LNs to the
skin where they display inhibitory effects and then come back to
the LNs (Tomura et al., 2010).
Regular stimulation by gut antigen also contributes to main-
taining Tregs in the gut. The T-cell receptor (TCR) repertoire of
Tregs from the small intestinal LP is highly overlapping with the
TCR repertoire of Tregs from gut-draining mLNs (Föhse et al.,
2011). A substantial number of GALT-associated iTregs is likely
to arise after induction by colonic microbiota-derived antigen
(Lathrop et al., 2011). Thymic nTregs were shown to have the
TCR repertoire that is skewed toward self-antigens while the TCR
repertoire of iTregs is biased toward non-self-antigens (Hsieh
et al., 2006). However, the TCR repertoire of thymus-derived
Tregs in colon-associated lymphoid and non-lymphoid tissues is
heavily influenced by the composition of the microbiota suggest-
ing that nTregs are involved in mucosal tolerance to commensal
microorganisms (Cebula et al., 2013).
Mechanisms of induction of mucosal tolerance are summa-
rized in Figure 1.
IMPACT OF GUT MICROBIOTA TO MUCOSAL TOLERANCE
THE STABLE GUT MICROBIOTA IS BENEFICIAL FOR HUMAN HEALTH
The regular intake of beneficial microorganisms (probiotics) is
believed to confer health advances on the host. The probiotics
such as lactobacilli and bifidobacteria exhibit a range of beneficial
effects on the host health including competition with pathogenic
microbes for nutrients, supply with vitamin K, inactivation of
xenobiotics, stimulating colon peristalsis, digestion of indigestible
food fibers, and modulation of the host’s immune system (Hardy
et al., 2013). In addition, non-pathogenic commensal bacteria
such as Escherichia coli were shown to inhibit growth and expan-
sion of pathogens through secretion of antimicrobial peptides
(bacteriocin, colicin M, microsin S; Kamenšek and Žgur-Bertok,
2013). Furthermore, several probiotics could cooperate (e.g.,
form synbiotics) in order to selectively promote the growth of one
or more beneficial probiotic species (van Zanten et al., 2012).
The human body plays host to communities of beneficial
commensal microorganisms (gut microbiota) that mediate key
physiological processes in exchange for nutrients and a sheltered
habitat in which they are able to reproduce. In the human
intestinal commensal microbiota, the Firmicutes and the Bac-
teroidetes are the two prevalent phylogenetic types (Eckburg
et al., 2005). The stomach contains low numbers of commensal
bacteria with predominating species of Lactobacillus, Streptococ-
cus, and Helicobacter pylori. In the small intestine, Streptococcus
and Lactobacillus species are predominant. In the large intestine
and distal gut, the Bacteroides, Clostridium, Fusobacterium, and
Bifidobacterium are prevalent (Eckburg et al., 2005). Indeed, since
strain and density range of commensal bacteria greatly vary along
the gastrointestinal tract, antimicrobial peptide production and
effects of microbiota to the host’s immune system also markedly
vary from one location to another in the gut. In pathogenic
conditions such as inflammatory bowel disease, these beneficial
stable microbiomes are subjected to dramatic changes associated
with decreased microbial diversity and unfavorable shift toward
increased numbers of gram-negative bacteria (Qin et al., 2010).
The colonization of the newborn intestine is the important
stage in the development of future stable gut microbiota. Lower
numbers of initial colonizing bacteria, in particular bifidobacte-
ria, may impede establishment of a stable gut microbiota during
a critical period of immune education and development. Human
milk have was found to provide early immune education and pas-
sive immunity through the cooperative action of various bioac-
tive molecules and cells including immunoglobulins, lysozyme,
lactoferrin (Grzelak et al., 2014) as well as being a source of
commensals such as L. acidophilus, L. gasseri, Bifidobacterium
bifidum, and Bifidobacterium breve (Martín et al., 2003).
The generation of germ-free mice provided a good option for
evaluating the role of the microbiota composition on the immune
system. The lack of microbial stimulation leads to maturation
defects in lymphoid organs such as PPs and spleen, abnormalities
in numbers of immune cells, and altered cytokine expression
(Pollard and Sharon, 1970; Bartizal et al., 1984; Williams et al.,
2006). Some gut bacteria were shown to play a significant role
in the development of GALT. Bacteroides fragilis (B. fragilis) and
Bacillus subtilis could stimulate transcytosis in M cells through
induction of stress responses to secretion of bacterial protein
YqxM essential for sporulation and biofilm formation (Rhee et al.,
2004; Chu et al., 2006).
The effects of imbalanced microbiota are not restricted to
gastrointestinal abnormalities but could have systemic impact on
immunity especially in allergic disorders (Russell et al., 2013)
and autoimmune diseases such as multiple sclerosis (Ochoa-
Repáraz et al., 2010) and type 1 diabetes (King and Sarvetnick,
2011). Such findings further support the “hygiene hypothesis”
suggesting that the absence of immune challenges, result in the
insufficient maturation of the immune system and predispose to
certain allergic and autoimmune disorders such as celiac disease,
asthma, inflammatory bowel disease, type 1 diabetes, etc. (Stra-
chan, 1989).
INTESTINAL MICROBIOTA AND IMMUNE HOMEOSTASIS
The intestinal microbiota is a crucial component of the immuno-
logic milieu that creates the substrate for oral tolerance (Strober,
2009). The recognition of intestinal bacteria triggers the choice
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FIGURE 1 | Mechanisms of induction of mucosal tolerance. Intestinal
antigens could pass from the gut to the GALT through M cells, be collected
by DCs, and taken up by enterocytes. GALT-associated DCs have a unique
capacity to direct differentiation of regulatory T cells (Tregs) from forkhead
box protein 3 (FoxP3)− T cells. These properties of tolerogenic dendritic cells
(DCs) are modulated by commensal colon microbiota, transforming growth
factor-β (TGF-β), and interleukin (IL-10) produced by enterocytes. Tolerogenic
DCs secrete retinoic acid that is synthesized from dietary vitamin A and is
essential for formation of inducible Tregs (iTregs). CD11b monocytes also
contribute to the induction of Tregs. Treg induction occurs in mesenteric
lymph nodes and involves C-C motif receptors (CCR)-7 and -9. Low doses of
intestinal antigen lead to the induction of Tregs while high antigen doses
result in tolerance induction preferentially through the mechanisms of anergy
and deletion. Macrophages activated by clearance of apoptotic T cells and
enterocytes become to produce TGF-β and therefore could possess
tolerogenic properties. In the liver, high antigen doses could be taken up by
tolerogenic plasmacytoid DCs that induce anergy/deletion and Tregs. A
variety of Tregs could be induced including CD4+CD25+Foxp3+ natural Tregs
(nTregs), CD4+CD25+Foxp3+ iTregs, latency-associated peptide (LAP)+
Tregs (Th3 cells), CD8+ Tregs, and γδ T cells.
of the subsequent GALT-mediated immune response that should
be positive (e.g., stimulatory) in case of pathogens or negative
(e.g., tolerogenic) in case of commensal microbes. The host innate
immunity of host organism is primarily responsible for recogni-
tion of pathogens.
Toll-like receptors and other pathogen-sensing molecules that
are highly expressed by enterocytes and mucosal APCs (DCs
and macrophages) respond to pathogen-associated molecular
patterns (PAMPs; Chu and Mazmanian, 2013). The recognition
of pathogens results in induction of antiviral or proinflammatory
response against infection.
In the gut epithelium, expression of TLRs is down-regulated
on the apical membrane compared to the basolateral side. Low
expression of TLR2 and TLR4 is observed on the apical mem-
brane. These receptors prime tolerance to cell wall constituents of
commensal bacteria such as lipopolysaccharides (LPS) and pepti-
doglycans (Fukase et al., 2003; Abreu, 2010). Normally, E. coli flag-
ellin does not induce any TLR5-mediated inflammatory response.
However, basolateral activation of TLR5 by flagellin derived from
pathogenic bacteria such as Salmonella results in induction of
the acute intestinal inflammation associated with transfer of
pathogenic flagellin through gut epithelial cells (Gewirtz et al.,
2001). Therefore, when stable and normal microbiota is present in
the gut, intestinal epithelial cells are irresponsive to flagellin while
flagellin-dependent stimulation of the basolateral epithelial sur-
face is recognized as pathogenic and stimulates TLR5-mediated
proinflammatory response (Maaser et al., 2004).
Gram-negative commensal bacteria are major LPS producers
in the gut. The epithelial alkaline phosphatase dephosphory-
lates bacterial LPS that become tolerogenic due to inability to
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stimulate TLR9 (Lee et al., 2007). In the intestinal epithelium,
alkaline phosphatase is concentrated closely to the apical mem-
brane thereby contributing to induction of either inflammatory
or immunosuppressive tolerogenic response (Lee et al., 2006).
Indeed, bacterial PAMPs are involved not only in the induction of
activatory immune responses but also in induction of intestinal
tolerance.
The GALT and intestinal epithelium can explore several
options to down-regulate TLR-dependent immune stimulation
including decrease of TLR expression, release of soluble immune
receptors such as soluble TLR2, TLR4, and ST2 (Schmitz
et al., 2005), and up-regulation of intracellular inhibitors of
TLR signaling including MyD88s (a splice variant of myeloid
differentiation factor 88), Toll-interacting protein (Tollip), TNF-
related apoptosis-inducing ligand receptor (TRAIL-R), selective
androgen receptor modulator (SARM), and others (Shibolet and
Podolsky, 2007). Decoy receptors such as ST2 ligand and single Ig
IL-1-related receptor (SIGIRR) also could contribute to colonic
epithelial homeostasis by inhibiting TLR-induced gut inflamma-
tion (Xiao et al., 2007).
A growing number of evidence shows that intestinal commen-
sal microbiota modulate Treg-mediated responses essential for
establishing effective protection against pathogens and prevention
of autoimmunity, food allergy, gut hypersensitivity to gut-derived
antigens, and other unpleasant immunopathologic conditions.
Germ-free mice colonized with commensal Clostridium species
taken from the normal human microbiota developed IL-10-
producing CD4+FoxP3+ Tregs (Atarashi et al., 2011, 2013).
The community of 17 strains of Clostridia provided bacterial
antigens and a TGF-β-rich environment to support induction,
proliferation, and expansion of Tregs. Colonization of germ-free
animals with human commensal B. fragilis induced development
of FoxP3+ Tregs associated with production of anti-inflammatory
cytokines (Round and Mazmanian, 2010). B. fragilis was found to
secrete polysaccharide A. It has also been shown that B. fragilis
mediates the conversion of CD4+ T cells into Foxp3+ Treg cells
that produce IL-10 (Round and Mazmanian, 2010). Furthermore,
bacterial polysaccharide A was not only able to prevent but also
heal experimental colitis in animals suggesting for the involve-
ment of gut commensal microbe B. fragilis to mucosal tolerance
(Round and Mazmanian, 2010). In addition to live microbiota,
LPS derived from the intestinal commensal bacteria could also
modulate the mucosal immunity. In germ-free mice, LPS-rich
sterile diet led to GALT-associated proliferation and expansion
of CD4+ T cells and notably to expansion of Foxp3+ Tregs in
mLNs. Both intestinal microbiota and LPS-rich diet were able
to increase production of proinflammatory IL-12 and decrease
production of IL-4 essential for differentiation of naïve T cells to
pro-inflammatory Th2 cells (Hrncir et al., 2008).
Long-term treatment with antibiotics were shown to deplete
normal gut microbiota causing systemic decrease in proliferation
of CD4+ T cells while Foxp3+ Treg proliferation was only locally
impaired in the GALT (Cording et al., 2013). In line with this,
MyD88-null mice as well as animals deficient for various TLRs
showed normal or even increased proliferation of conventional
CD4+ T cells and Foxp3+ Tregs (Atarashi et al., 2011). Indeed,
these findings suggest that TLR-mediated recognition of colon-
derived bacterial components is not a major mechanism of
induction of T cell homeostasis driven by commensal micro-
biota (Cording et al., 2013). Except for TLRs, other molecular
sensors of microbe-derived antigens exist. Those include RIG-
I-like receptors (RLPs), NOD-like receptors (NLRs), and DNA-
sensing cytosolic receptors (Kumar et al., 2011; Jin and Flavell,
2013). Thus, other, TLR-independent PAMP-sensing mechanisms
or metabolic influences could also be involved in the colonic
microbiota-dependent control of T cell proliferation.
Animal models of experimentally induced autoimmune dis-
orders suggest the link between the microbial inhabitants of
the gastrointestinal tract and autoimmunity. Non-obese diabetic
(NOD) mice, a model for type 1 diabetes, which lacks MyD88,
an essential signaling component of innate immunity linking
microbe-sensing immune receptors with immune signaling cas-
cades is resistant to type 1 diabetes. However, germ-free MyD88-
null NOD mice develop severe diabetes while colonization of
germ-free MyD88-null NOD mice with microbiota mimicking
normal human gut microbiota reduces diabetes (Wen et al., 2008).
In the model of experimental autoimmune encephalomyelitis
(EAE), oral administration of Lactobacillus was shown to attenu-
ate disease (Maassen and Claassen, 2008) and cause changes in gut
microbiota, decrease in proinflammatory cytokines, and increase
in production of anti-inflammatory cytokines IL-10 and IL-13
(Ochoa-Repáraz et al., 2009). Similarly, oral administration of a
zwitterionic capsular polysaccharide A from human commensal
bacterium B. fragilis was found to protect against EAE through
induction of oral tolerance mediated by tolerogenic CD103+ DCs
and IL-10-producing FoxP3+ Tregs in the GALT (Ochoa-Repáraz
et al., 2010). In addition, non-filamentous ATP-producing gut
microbiota (Atarashi et al., 2008) and intestinal segmental fila-
mentous bacteria (Ivanov et al., 2008) were reported to specifically
prime the development of proinflammatory Th17-polarizing DCs
but did not affect IFN-γ-producing Th1 cells and FoxP3+ Tregs
subsets (Ivanov et al., 2009). Intestinal filamentous bacteria were
found to contribute to the pathogenesis of autoimmune arthritis
through stimulation of proinflammatory Th17 cells (Wu et al.,
2010). Therefore, filamentous bacteria represent an intriguing
example of commensal microbiota capable of shifting the mucosal
effector T cell inflammatory/tolerogenic balance and thus affect
the immune fitness of the individual (Ivanov and Littman, 2010).
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